Sienna Biopharmaceuticals, Inc. Proceeds from Long-Term Debt Issued
Sienna Biopharmaceuticals, Inc. reported Proceeds from Long-Term Debt Issued of $29.87 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-03-14
- Sienna Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $13.00K.
- Sienna Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was -$44.00K.
- Sienna Biopharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2018 was $29.87M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$31.00K derived: sum of 2 quarters · filed 2019-03-14 | $29.87M 10-K · filed 2019-03-14 | |
| 2018-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $29.85M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $29.90M 10-Q · filed 2018-08-09 |